Company Active LTD

Company profile

Tusk Therapeutics Ltd

Home

As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

CRN
09918170
Founded
2015
Age
10

Overview

Legal name
TUSK THERAPEUTICS LTD
Region
East of England
Registered address
6 FALCON WAY
SHIRE PARK
WELWYN GARDEN CITY
HERTFORDSHIRE
UNITED KINGDOM
AL7 1TW
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Tusk Therapeutics Ltd
CRN 09918170
2
Direct and ultimate controller
CHE101602521
CRN CHE101602521

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

29 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

15 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

16 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNTk4Njk0MmFkaXF6a2N4

Published 16 Sep 2024 10:15

19 Aug
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzMjE0NzQzMWFkaXF6a2N4 | Paper/PDF filed

Published 20 Aug 2024 08:00

16 Dec
2015

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2018
Funded years
2018
Age at first award
2 years

Projects

2018 Collaborative R&D Lead participant

Novel CD38 Targeting Cancer Immunotherapy

1 Jan 2018 to 30 Apr 2020

Awarded
£2,454,273
Total cost £3,506,104

Tusk Therapeutics is a UK biotechnology company with a focus on harnessing the power of the immune system to fight cancer through the development of novel immune modulating therapeutics. The company has established a diversified pipeline of antibodies against both novel and validated targets that play an important role in the body’s immune response to can...

Product types

Collaborative R&D